Cellebrite DI Ltd. (CLBT) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-05-14

Key Insights

President of Products & Technology acquired 423,550 ordinary shares through RSU vesting with staggered schedule: 105,898 shares vesting May 4, 2027, then 26,471 shares quarterly through May 4, 2030, indicating multi-year equity retention program.
RSU award at $0 price represents compensation arrangement rather than open market purchase, suggesting this is part of executive incentive structure rather than insider confidence signal through direct buying.
Officer's base equity stake post-transaction is 423,550 shares held directly, establishing significant personal financial alignment with company performance over the next 4-year vesting period.

Want the newest filings?

This analysis covers the filing from 2026-05-14. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-05-14

Global Chief Revenue Officer Marcus Jewell sold 383 ordinary shares on May 12, 2026, at a weighted average price of $13.01, reducing his direct beneficial ownership to 452,759 shares.
The sale was driven by tax obligations from RSU vesting (granted February 11, 2025) rather than a loss of confidence in the company, as shares were sold across a narrow price range ($12.84-$13.175) indicating a systematic tax-driven transaction.
The CRO maintained substantial shareholdings of 452,759 shares post-transaction, suggesting continued confidence in Cellebrite's future despite the equity reduction for tax purposes.

Filed: 2026-05-14

Chief Marketing Officer David Gee sold 228 ordinary shares on May 12, 2026, at a weighted average price of $13.01, reducing his beneficial ownership to 147,705 shares.
The share disposition was driven by tax obligations from the vesting of RSUs granted on February 11, 2025, indicating this was a forced sale for tax compliance rather than a loss of confidence in the company.
The shares were sold across multiple transactions within a narrow price range ($12.84-$13.175), suggesting orderly execution consistent with pre-planned tax withholding arrangements rather than urgent liquidation.

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.